Roles of TGFβ signaling in epidermal/appendage development

Cytokine and Growth Factor Reviews

Volumn 14, Issue 2, 2003, Pages 99-111

  Li, Allen G ^a   Koster, Maranke I ^a   Wang, Xiao Jing ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Activin; BMP; Epidermal development; Hair follicle morphogenesis; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; ACTIVIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR; WNT PROTEIN; ZEBRAFISH PROTEIN;

EPIDERMIS; MORPHOGENESIS; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; SHORT SURVEY; SIGNAL TRANSDUCTION; SKIN APPENDAGE; ANIMAL; BIOLOGICAL MODEL; HUMAN; LIMB; METABOLISM; MOUSE; PHENOTYPE; PHYSIOLOGY; PRENATAL DEVELOPMENT; REVIEW; TIME; TRANSGENIC MOUSE;

ACTIVINS; ANIMALS; EPIDERMIS; EXTREMITIES; HUMANS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; NF-KAPPA B; PHENOTYPE; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0037379668     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(03)00005-4     Document Type: Short Survey

References (149)

1. Nadeau A, Grondin G, Blouin R. In situ hybridization analysis of ZPK gene expression during murine embryogenesis. J Histochem Cytochem 1997;45:107-18.
2. Byrne C, Tainsky M, Fuchs E. Programming gene expression in developing epidermis. Development 1994;120:2369-83.
3. Bickenbach JR, Greer JM, Bundman DS, Rothnagel JA, Roop DR. Loricrin expression is coordinated with other epidermal proteins and the appearance of lipid lamellar granules in development. J Invest Dermatol 1995;104:405-10.
4. Vielkind U, Hardy MH. Changing patterns of cell adhesion molecules during mouse pelage hair follicle development. 2. Follicle morphogenesis in the hair mutants, Tabby and downy. Acta Anat (Basel) 1996;157:183-94.
5. Lyons KM, Pelton RW, Hogan BL. Organogenesis and pattern formation in the mouse: RNA distribution patterns suggest a role for bone morphogenetic protein-2A (BMP-2A). Development 1990;109:833-44.
6. Hardy MH. The secret life of the hair follicle. Trends Genet 1992;8:55-61.
7. Philpott MP, Paus R. Principles of hair follicle morphogenesis. In: Chuong CM, editor. Molecular basis of epithelial appendage morphogenesis. Austin: Landes Biosciences Publishers; 1998. p. 75-103.
8. Paus R, Cotsarelis G. The biology of hair follicles. N Engl J Med 1999;341:491-7.
9. Fuchs E, Merrill BJ, Jamora C, DasGupta R. At the roots of a never-ending cycle. Dev Cell 2001;1:13-25.
10. Millar SE. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002;118:216-25.
11. Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev 2001;81:449-94.
12. Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990;61:1329-37.
13. Cotsarelis G, Kaur P, Dhouailly D, Hengge U, Bickenbach J. Epithelial stem cells in the skin: definition, markers, localization and functions. Exp Dermatol 1990;8:80-8.
14. Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell 2001;104:233-45.
15. Botchkarev VA, Botchkareva NV, Nakamura M, Huber O, Funa K, Lauster R, et al. Noggin is required for induction of the hair follicle growth phase in postnatal skin. FASEB J 2001;15:2205-14.
16. Hoodless PA, Wrana JL. Mechanism and function of signaling by the TGF-beta superfamily. Curr Top Microbiol Immunol 1998;228:235-72.
17. Chang H, Lau AL, Matzuk MM. Studying TGF-beta superfamily signaling by knockouts and knockins. Mol Cell Endocrinol 2001;180:39-46.
18. Massague J, Blain SW, Lo RS. TGF-beat signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
19. Hartsough MT, Mulder KM. Transforming growth factor-beta signaling in epithelial cells. Pharmacol Ther 1997;75:21-41.
20. Roberts AB, Sporn M. The transforming growth factor-beta. In: Sporn M, Roberts AB, editors. Peptides, growth factors and their receptors, vol. I. Berlin: Springer; 1990. p. 419-72.
21. Yue J, Mulder KM. Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 2001;91:1-34.
22. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998;67:753-91.
23. Massague J. How cells read TGF-beta signals. Nat Rev Mol Cell Biol 2000;1:169-78.
24. Derynck R, Zhang Y, Feng XH. Smads: transcriptional activators of TGF-beta responses. Cell 1998;95:737-40.
25. Kawabata M, Miyazono K. Signal transduction of the TGF-beta superfamily by Smad proteins. J Biochem (Tokyo) 1999;125:9-16.
26. Padgett RW, Cho SH, Evangelista C. Smads are the central component in transforming growth factor-beta signaling. Pharmacol Ther 1998;78:47-52.
27. Liu X, Sun Y, Constantinescu SN, Karam E, Weinberg RA, Lodish HF. Transforming growth factor-beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc Natl Acad Sci USA 1997;94:10669-74.
28. Goto D, Yagi K, Inoue H, et al. A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals. FEBS Lett 1998;430:201-4.
29. Souchelnytskyi S, Tamaki K, Engstrom U, Wernstedt C, ten Dijke P, Heldin CH. Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J Biol Chem 1997;272:28107-15.
30. Imamura T, Takase M, Nishihara A, et al. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 1997;389:622-6.
31. Nakao A, Afrakhte M, Moren A, et al. Identification of Smad7, a TGF-beat-inducible antagonist of TGF-beta signaling. Nature 1997;389:631-5.
32. Meno C, Gritsman K, Ohishi S, et al. Mouse Lefty2 and zebrafish antivin are feedback inhibitors of nodal signaling during vertebrate gastrulation. Mol Cell 1999;4:287-98.
33. Hartsough MT, Mulder KM. Transforming growth factor-beta activation of p44mapk in proliferating cultures of epithelial cells. J Biol Chem 1995;270:7117-24.
34. Adachi-Yamada T, Nakamura M, Irie K, et al. p38 mitogen-activated protein kinase can be involved in transforming growth factor-beta superfamily signal transduction in Drosophila wing morphogenesis. Mol Cell Biol 1999;19:2322-9.
35. Hocevar BA, Brown TL, Howe PH. TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4independent pathway. EMBO J 1999;18:1345-56.
36. Takatsu Y, Nakamura M, Stapleton M, et al. TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development. Mol Cell Biol 2000;20:3015-26.
37. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-betamediated transcription. J Biol Chem 1999;274:37413-20.
38. Zimmerman LB, Jesus-Escobar JM, Harland RM. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996;86:599-606.
39. Botchkarev VA, Botchkareva NV, Roth W, et al. Noggin is a mesenchymally derived stimulator of hair-follicle induction. Nat Cell Biol 1999;1:158-64.
40. Fukui A, Nakamura T, Sugino K, et al. Isolation and characterization of Xenopus follistatin and activins. Dev Biol 1993;159:131-9.
41. Iemura S, Yamamoto TS, Takagi C, et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 1998;95:9337-42.
42. Chen YG, Lui HM, Lin SL, Lee JM, Ying SY. Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Exp Biol Med (Maywood) 2002;227:75-87.
43. He W, Cao T, Smith DA, Myers TE, Wang X-J. Smads mediate signaling of the TGF-beat superfamily in normal keratinocytes but are lost during skin chemical carcinogenesis. Oncogene 2001;20:471-83.
44. Lechleider RJ, Ryan JL, Garrett L, et al. Targeted mutagenesis of Smad1 reveals an essential role in chorioallantoic fusion. Dev Biol 2001;240:157-67.
45. Nomura M, Li E. Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 1998;393:786-90.
46. Waldrip WR, Bikoff EK, Hoodless PA, Wrana JL, Robertson J. Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 1998;92:797-808.
47. Sirard C, de la Pompa JL, Elia A, et al. The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 1998;12:107-19.
48. Yang X, Castilla LH, Xu X, et al. Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5. Development 1999;126:1571-80.
49. Galvin KM, Donovan MJ, Lynch CA, et al. A role for Smad6 in development and homeostasis of the cardiovascular system. Nat Genet 2000;24:171-4.
50. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF. Targeted disruption of Smad3 reveals an essential role in transforming growth factor-beta-mediated signal transduction. Mol Cell Biol 1991;19:2495-504.
51. Yang X, Letterio JJ, Lechleider RJ, et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999;18:1280-91.
52. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998;94:703-14.
53. He W, Li AG, Wang D, et al. Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J 2002;21:2580-90.
54. He W, Wang D, Goumans MJ, ten Dijke P, Sundberg JP, Wang X-J. Smad7 transgenic mice exhibit a severe delay in hair follicle development, aberrant follicle morphogenesis and differentiation, and cyclical balding. J Invest Dermatol 2002;119:286- [abstract].
55. Ahmad W, Panteleyev AA, Christiano AM. The molecular basis of congenital atrichia in humans and mice: mutations in the hairless gene. J Invest Dermatol Symp Proc 1999;4:240-3.
56. Panteleyev AA, Botchkareva NV, Sundberg JP, Christiano AM, Paus R. The role of the hairless (hr) gene in the regulation of hair follicle catagen transformation. Am J Pathol 1999;155:159-71.
57. Paus R. Principles of hair cycle control. J Dermatol 1998;25:793-802.
58. Foitzik K, Paus R, Doetschman T, Dotto GP. The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. Dev Biol 1999;212:278-89.
59. Matzuk MM, Kumar TR, Vassalli A, et al. Functional analysis of activins during mammalian development. Nature 1995;374:354-6.
60. Kulessa H, Turk G, Hogan BL. Inhibition of Bmp signaling affects growth and differentiation in the anagen hair follicle. EMBO J 2000;19:6664-74.
61. Wang X-J, Liefer KM, Tsai S, O'Malley BW, Roop DR. Development of gene-switch transgenic mice that inducibly express transforming growth factor-beta1 in the epidermis. Proc Natl Acad Sci USA 1999;96:8483-8.
62. Cao T, He W, Roop DR, Wang X-J. K14-GLp65 transactivator induces transgene expression in embryonic epidermis. Genesis 2002;32:189-90.
63. Sellheyer K, Bickenbach JR, Rothnagel JA, et al. Inhibition of skin development by overexpression of transforming growth factor-beta1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 1993;90:5237-41.
64. Liu X, Alexander V, Vijayachandra K, Bhogte E, Diamond I, Glick A. Conditional epidermal expression of TGF-beat 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 2001;98:9139-44.
65. Pittelkow MR, Coffey Jr RJ, Moses HJ. Keratinocytes produce and are regulated by transforming growth factors. Ann NY Acad Sci 1988;548:211-24.
66. Shah M, Foreman DM, Ferguson MW. Control of scarring in adult wounds by neutralising antibody to transforming growth factor-beta. Lancet 1992:339:213-4.
67. Koli K, Keski-Oja J. Transforming growth factor-beta system and its regulation by members of the steroid-thyroid hormone superfamily. Adv Cancer Res 1996;70:63-94.
68. Gentry LE, Lioubin MN, Purchio AF, Marquardt H. Molecular events in the processing of recombinant type 1 pre-pro-transforming growth factor-beta to the mature polypeptide. Mol Cell Biol 1988;8:4162-8.
69. Lawrence DA, Pircher R, Kryceve-Martinerie C, Jullien P. Normal embryo fibroblasts release transforming growth factors in a latent form. J Cell Physiol 1984;121:184-8.
70. Lawrence DA. Identification and activation of latent transforming growth factor-beta. Methods Enzymol 1991;198:327-36.
71. Miyazono K, Ichijo H, Heldin CH. Transforming growth factor-beta: latent forms. Growth Factors 1993;8:11-22.
72. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, Purchio AF. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor-beta1 precursor. Expression and characterization of mutant proteins. J Biol Chem 1989;264: 13660-4.
73. Diebold RJ, Eis MJ, Yin M, et al. Early-onset multifocal inflammation in the transforming growth factor-beta1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 1995;92:12215-9.
74. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGF-beat2 knockout mice have multiple developmental defects that are non-overlapping with other TGF-beat knockout phenotypes. Development 1997;124:2659-70.
75. Kaartinen V. Voncken JW, Shuler C, et al. Abnormal lung development and cleft palate in mice lacking TGF-beta3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11:415-21.
76. Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-beta3 is required for secondary palate fusion. Nat Genet 1995;11:409-14.
77. Pelton RW, Saxena B, Jones M, Moses HL, Gold LI. Immunohistochemical localization of TGF beta1, TGF-beta2, and TGF-beta3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development. J Cell Biol 1991;115:1091-105.
78. Foitzik K, Lindner G, Mueller-Roever S, et al. Control of murine hair follicle regression (catagen) by TGF-betal in vivo. FASEB J 2000;14:752-60.
79. Welker P, Foitzik K, Bulfone-Paus S, Henz BM, Pans R. Hair cycle-dependent changes in the gene expression and protein content of transforming factor-beta1 and beta3 in murine skin. Arch Dermatol Res 1997;289:554-7.
80. Soma T, Tsuji Y, Hibino T. Involvement of transforming growth factor-beta2 in catagen induction during the human hair cycle. J Invest Dermatol 2002;118:993-7.
81. Paus R, Foitzik K, Welker P, Bulfone-Paus S, Eichmuller S. Transforming growth factor-beta receptor type I and type II expression during murine hair follicle development and cycling. J Invest Dermatol 1997;109:518-26.
82. Oshima M, Oshima H, Taketo MM. TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996;179:297-302.
83. Larsson J, Goumans MJ, Sjostrand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 2001;20:1663-73.
84. Amendt C, Schirmacher P. Weber H, Blessing M. Expression of a dominant negative type II TGF-beta receptor in mouse skin results in an increase in carcinoma incidence and an acceleration of carcinoma development. Oncogene 1998;17:25-34.
85. Wang X-J, Greenhalgh DA, Bickenbach JR, et al. Expression of a dominant-negative type II transforming growth factor-beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition. Proc Natl Acad Sci USA 1997;94:2386-91.
86. Gaddy-Kurten D, Tsuchida K, Vale W. Activins and the receptor serine kinase superfamily. Recent Prog Horm Res 1995;50:109-29.
87. Peng C, Mukai ST. Activins and their receptors in female reproduction. Biochem Cell Biol 2000;78:261-79.
88. Ball EM, Risbridger GP. Activins as regulators of branching morphogenesis. Dev Biol 2001;238:1-12.
89. Roberts VJ, Sawchenko PE, Vale W. Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 1991;128:3122-9.
90. Roberts VJ, Barth SL. Expression of messenger ribonucleic acids encoding the inhibin/activin system during mid- and late-gestation rat embryogenesis. Endocrinology 1994;134:914-23.
91. Munz B, Smola H, Engelhardt F, et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999;18:5205-15.
92. Munz B, Tretter YP, Hertel M, Engelhardt F, Alzheimer C, Werner S. The roles of activins in repair processes of the skin and the brain. Mol Cell Endocrinol 2001;180:169-77.
93. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR, Bradley A. Multiple defects and perinatal death in mice deficient in follistatin. Nature 1995;374:360-3.
94. Guo Q, Kumar TR, Woodruff T, Hadsell LA, DeMayo FJ, Matzuk MM. Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol Endocrinol 1998;12:96-106.
95. Ducy P, Karsenty G. The family of bone morphogenetic proteins. Kidney Int 2000;57:2207-14.
96. Wilson PA, Hemmati-Brivanlou A. Induction of epidermis and inhibition of neural fate by BMP4. Nature 1995;376:331-3.
97. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995;9:2105-16.
98. Jones CM, Lyons KM, Hogan BL. Involvement of bone morphogenetic protein-4 (BMP4) and Vgr-1 in morphogenesis and neurogenesis in the mouse. Development 1991;111:531-42.
99. Bitgood MJ, McMahon AP. Hedgehog and Bmp genes are coexpressed at many diverse sites of cell-cell interaction in the mouse embryo. Dev Biol 1995;172:126-38.
100. Headon DJ, Overbeek PA. Involvement of a novel TNF receptor homologue in hair follicle induction. Nat Genet 1999;22:370-4.
101. Neubuser A, Peters H, Balling R, Martin GR. Antagonistic interactions between FGF and BMP signaling pathways: a mechanism for positioning the sites of tooth formation. Cell 1997;90:247-55.
102. Jung HS, Francis-West PH, Widelitz RB, et al. Local inhibitory action of BMPs and their relationships with activators in feather formation: implications for periodic patterning. Dev Biol 1998;196:11-23.
103. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995;9:3027-37.
104. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev 1996;6:432-8.
105. Blessing M, Nanney LB, King LE, Jones CM, Hogan BL. Transgenic mice as a model to study the role of TGF-beta-related molecules in hair follicles. Genes Dev 1993;7:204-15.
106. Botchkarev VA, Botchkareva NV, Sharov AA, Funa K, Huber O, Gilchrest BA. Modulation of BMP signaling by noggin is required for induction of the secondary (non-tylotrich) hair follicles. J Invest Dermatol 2002;118:3-10.
107. Widelitz RB, Jiang TX, Noveen A, Chen CW, Chuong CM. FGF induces new feather buds from developing avian skin. J Invest Dermatol 1996;107:797-803.
108. Gat U, DasGupta R, Degenstein L, Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 1998:95:605-14.
109. Noramly S, Morgan BA. BMPs mediate lateral inhibition at successive stages in feather tract development. Development 1998;125:3775-87.
110. Wilson N, Hynd PI, Powell BC. The role of BMP2 and BMP4 in follicle initiation and the murine hair cycle. Exp Dermatol 1999;8:367-8.
111. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51.
112. van Genderen C, Okamura RM, Farinas I, et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 1994;8:2691-703.
113. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001;105:533-45.
114. DasGupta R, Rhee H, Fuchs E. A developmental conundrum: a stabilized form of beta-catenin lacking the transcriptional activation domain triggers features of hair cell fate in epidermal cells and epidermal cell fate in hair follicle cells. J Cell Biol 2002;158: 331-44.
115. Kratochwil K, Dull M, Farinas I, Galceran J, Grosschedl R. Lef1 expression is activated by BMP4 and regulates inductive tissue interactions in tooth and hair development. Genes Dev 1996;10:1382-94.
116. Waikel RL, Wang X-J, Roop DR. Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-B induced apoptosis. Oncogene 1999;18:4870-8.
117. Pietenpol JA, Stein RW, Moran E, et al. TGF-beta1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 1990;61:777-85.
118. Pietenpol JA, Holt JT, Stein RW, Moses HL. Transforming growth factor-beta1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 1990;87:3758-62.
119. Feng XH, Liang YY, Liang M, Zhai W, Lin X. Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B), Mol Cell 2002;9: 133-43.
120. Waikel RL, Kawachi Y, Waikel PA, Wang X-J, Roop DR. Deregulated expression of c-Myc depletes epidermal stem cells. Nat Genet 2001;28:165-8.
121. Niemann C, Watt FM. Designer skin: lineage commitment in postnatal epidermis. Trends Cell Biol 2002;12:185-92.
122. Iseki S, Araga A, Ohuchi H, et al. Sonic hedgehog is expressed in epithelial cells during development of whisker, hair, tooth. Biochem Biophys Res Commun 1996;218:688-93.
123. Oro AE, Higgins KM, Hu Z, Bonifas JM, Epstein Jr EH, Scott MP. Basal cell carcinomas in mice overexpressing sonic hedgehog. Science 1997;276:817-21.
124. Chiang C, Swan RZ, Grachtchouk M, et al. Essential role for Sonic hedgehog during hair follicle morphogenesis. Dev Biol 1999;205:1-9.
125. Wang LC, Liu ZY, Gambardella L, et al. Conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol 2000;114:901-8.
126. St Jacques B, Dassule HR, Karavanova I, et al. Sonic hedgehog signaling is essential for hair development. Curr Biol 1998;8:1058-68.
127. Sato N, Leopold PL, Crystal RG. Induction of the hair growth phase in postnatal mice by localized transient expression of Sonic hedgehog. J Clin Invest 1999;855-64.
128. Ting-Berreth SA, Chuong CM. Local delivery of TGF-beta2 can substitute for placode epithelium to induce mesenchymal condensation during skin appendage morphogenesis. Dev Biol 1996;179:347-59.
129. Jung HS, Francis-West PH, Widelitz RB, et al. Local inhibitory action of BMPs and their relationships with activators in feather formation: implications for periodic patterning. Dev Biol 1998;196:11-23.
130. Kere J, Srivastava AK, Montonen O, et al. X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 1996;13:409-16.
131. Headon DJ, Emmal SA, Ferguson BM, et al. Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature 2001;414:913-6.
132. Laurikkala J, Pispa J, Jung HS, et al. Regulation of hair follicle development by the TNF signal ectodysplasin and its receptor Edar. Development 2002;129:2541-53.
133. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336: 1066-71.
134. Finco TS, Baldwin AS. Mechanistic aspects of NF-kappaB regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995;3:263-72.
135. Li Q, Lu Q, Hwang JY, et al. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev 1999;13:1322-8.
136. Hu Y, Baud V, Delhase M, et al. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 1999;284:316-20.
137. Hu Y, Baud V, Oga T, Kim KI, Yoshida K, Karin M. IKKalpha controls formation of the epidermis independently of NF-kappaB. Nature 2001;410:710-4.
138. Nagarajan RP, Chen F, Li W, et al. Repression of transforminggrowth-factor-beta-mediated transcription by nuclear factor kappaB. Biochem J 2000;348:591-6.
139. Arsura M, Wu M, Sonenshein GE. TGF-beta1 inhibits NF-kappaB/Rel activity inducing apoptosis of B cells: transcriptional activation of I kappaB alpha. Immunity 1996;5:31-40.
140. Bendall AJ, Abate-Shen C. Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 2000;247:17-31.
141. Koster MI, Huntzinger KA, Roop DR. Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation. J Invest Dermatol Symp Proc 2002;7:41-5.
142. Reginelli AD, Wang YQ, Sassoon D, Muneoka K. Digit tip regeneration correlates with regions of Msxl (Hox 7) expression in fetal and newborn mice. Development 1995;121:1065-76.
143. Satokata I, Maas R. Msxl deficient mice exhibit cleft palate and abnormalities of craniofacial and tooth development. Nat Genet 1994;6:348-56.
144. Satokata I, Ma L, Ohshima H, et al. Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat Genet 2000;24:391-5.
145. Jiang TX, Liu YH, Widelitz RB, Kundu RK, Maxson RE, Chuong CM. Epidermal dysplasia and abnormal hair follicles in transgenic mice overexpressing homeobox gene MSX-2. J Invest Dermatol 1999;113:230-7.
146. Suzuki A, Ueno N, Hemmati-Brivanlou A. Xenopus msx1 mediates epidermal induction and neural inhibition by BMP4. Development 1997;124:3037-44.
147. Sirard C, Kim S, Mirtsos C, et al. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor-beta-related signaling. J Biol Chem 2000;275:2063-70.
148. Yi SE, Daluiski A, Pederson R, Rosen V, Lyons KM. The type I BMP receptor BMPRIB is required for chondrogenesis in the mouse limb. Development 2000;127:621-30.
149. Gu Z, Reynolds EM, Song J, et al. The type I serine/threonine kinase receptor ActRIA (ALK2) is required for gastrulation of the mouse embryo. Development 1999;126:2551-61.